• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    FDA Issues Draft Guidance on NDI Enforcement Discretion

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Botanic Healthcare LLC

    Atlantia Clinical Trials

    ESHA Research

    Gencor

    Ecuadorian Rainforest
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Botanic Healthcare LLC

    Atlantia Clinical Trials

    ESHA Research

    Gencor

    Ecuadorian Rainforest
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Pet Supplements: A Regulatory Briefing

    The market for pet products continues expanding. Make sure you’re on solid legal footing.

    Pet Supplements: A Regulatory Briefing
    Related CONTENT
    • Asiamerica Group Inc.
    • Emerging Regulatory Pathways for Nutraceuticals
    • AHPA Adopts Guidance Policy on Hemp & Hemp-Derived CBD Products
    • GW Pharmaceuticals Receives ABC Tyler Award for Phytomedicinal Research
    • FDA Commissioner Scott Gottlieb to Resign
    By Todd Harrison & Michelle Jackson, Venable04.01.19
    Over the last decade, there has been an explosion of pet supplements being marketed in the U.S., but there still seems to be little understanding regarding the regulatory status of these formulations.
     
    In 1994, Congress passed the Dietary Supplement Health and Education Act (DSHEA), which defines a dietary supplement as a product intended to supplement the diet and that contains at least one or more of the following ingredients: a vitamin; a mineral; an herb or other botanical; an amino acid; a dietary substance for use to supplement the diet by increasing total dietary intake; or a concentrate, metabolite, constituent, extract or combination of any of the previously mentioned ingredients. 
     
    The main effect of DSHEA was to remove certain dietary ingredients from regulation as food additives, which requires premarket approval. However, in 1996, the Center for Veterinary Medicine (CVM) announced that DSHEA does not apply to animal products. Thus, many substances permitted in human dietary supplements may not be legally sold in animal supplements if they do not provide nutritive value to the target species’ diet.  
     
    In announcing that DSHEA does not apply to animal products, CVM reasoned that many substances that qualify as dietary supplements for human consumption, such as botanicals, have a history of use in humans that can be applied to establish reasonably safe levels. However, the same is not true for many of the same ingredients in animals. Animals may react very differently to substances than humans, and even small doses can cause adverse effects. Moreover, each animal species requires different nutrients, absorbs and metabolizes nutrients differently, and can exhibit different toxic reactions to food and its components. For instance, dogs are extremely sensitive to 9-delta THC, so giving your dog a THC gummy is not a wise choice.
     
    What’s Allowed?
    In general, the Food, Drug and Cosmetic Act (FDCA) requires that animal feeds be pure and wholesome, contain no harmful or deleterious substances, and be truthfully labeled. Currently, only those substances that are 1) common food ingredients, such as water, salt, and pepper; 2) listed as Generally Recognized As Safe (GRAS) in FDA regulations at 21 C.F.R. Parts 582 or 584; 3) listed as approved food additives in FDA regulations at 21 C.F.R. Part 573; or 4) listed as approved color additives for food in FDA regulations at 21 C.F.R. Parts 73, 74, or 81, are permitted in animal feeds, including animal/pet supplements that are being sold as feed.  
     
    In addition, the FDA has agreed to exercise its enforcement discretion to permit defined ingredients in the Official Publication of the Association of American Feed Control Officials (the AAFCO book) to be included in animal food, so long as 1) they are used as sources of nutrients, aroma, or taste and 2) there are no apparent safety concerns about the use or composition of the ingredient.1
     
    However, it is unclear how long the agency will continue to recognize the AAFCO book definitions. In a Memorandum of Understanding entered into in 2007 and renewed in March of 2015, FDA and AAFCO agreed to collaborate in the development and approval of animal feed ingredient definitions.2 
     
    However, also in March of 2015, FDA announced its intention to bring the AAFCO ingredient definitions and standards completely under the FDA GRAS and food additive framework.
     
    Specifically, the agency intends to (re)evaluate all feed ingredients that appear in the AAFCO book but are not listed in FDA regulations as GRAS or approved as food additives. FDA intends to determine whether there is sufficient scientific evidence to affirm the ingredient as GRAS or approve it as a food additive. When there is not sufficient evidence available for FDA to make a GRAS or food additive determination, the agency intends to require companies to submit food additive petitions in order to continue using an ingredient in animal feed products. Thus, while an ingredient might currently be permitted due to its listing in the AAFCO book, companies should understand that the permissibility of the ingredient is subject to change in the near future. 
     
    An Alternate Route
    With the above standard in mind, many unapproved ingredients are currently marketed for use in animal supplements, including burdock, comfrey, echinacea, ginseng, horsetail, and nettles. Currently, none of these ingredients are permitted for use in animal supplements. 
     
    However, because of the work of the National Animal Supplement Council a third option does exist. This route permits the marketing of dosage formed product with ingredients that are not included on the lists mentioned previously, or with claims that are not derived from the nutritive value of the product, with the knowledge that the product will technically be considered an unapproved new animal drug. 
     
    Generally, FDA considers these products to be “drugs of low regulatory priority” if the product does not pose a health or safety risk to the target animal, is not marketed with disease claims, and the claims are not generally false and misleading. (“Low regulatory priority” means that the products are low on FDA’s priority list with regard to enforcement, and the agency has generally not been active with enforcement actions in this area.)  
     
    Instead, enforcement is typically handled on the state level, which makes it a state-by-state issue. Some states are much more permissive when it comes to ingredients that are not included on one of the three lists discussed previously. However, there is a chance that one or more states will object to the sale of the product, and those states could ultimately suspend or prohibit the sale of the product in that state. Ultimately, it is a business decision for the company to make depending on how much risk it is willing to take.  
     
    Please note that in many states, if a product is intended to be used as an animal food ingredient, become part of an ingredient or food, or be added to an animal’s drinking water, the state automatically classifies the product as an animal food. In those states, any product that is intended to be ingested via one of these routes of administration but that does not meet the ingredient requirements discussed previously will be considered an adulterated feed.
     
    In certain states and under specific circumstances, a product that does not meet the definition of a food might be considered a “Dosage Form Animal Health Product.” Specifically, in order to qualify as a Dosage Form Animal Health Product, the article must be intended to support a specific structure or function of the body; be non-nutritional; not contain approved feed ingredients (i.e., no GRAS, approved food additive, or AAFCO ingredient); be in tablet, capsule, powder, or liquid form; and not contain directions to add the product to the feed or water of animals.
     
    If you intend to market the product as a Dosage Form Animal Health Product, we recommend you evaluate whether the product can be marketed under the National Animal Supplement Council (NASC) guidelines. Please note that not all non-feed supplements will appropriately fall under the NASC guidelines. If a product does meet the NASC guidelines, the council has published templates for labels for Dosage Form Animal Health Product that many states recognize. However, it is important to note that some states do not recognize the NASC template and may require a company to follow the feed regulations in that state.
     
    If you choose to go the route of a non-feed supplement, you may avoid the requirement to register with many states as an animal feed and may avoid the annual fees associated with the same. However, certain states do require the registration of Dosage Form Animal Health Products. Regardless, if you are looking into marketing a Dosage Form Animal Health Product we strongly encourage you to join NASC, as their work on behalf of the animal supplement market is the reason that federal and state regulators view the animal supplement industry favorably. 


    Todd Harrison
    Venable

    Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling, and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.

    Michelle Jackson 
    Venable

    Michelle Jackson is a partner with Venable. She focuses on regulatory counseling related to the development, design, formulation, manufacture, distribution, and promotion of Food and Drug Administration (FDA)-regulated products, including medical devices, foods, dietary supplements, drugs, homeopathic remedies, cosmetics, medical foods, and animal products, as well as in vitro diagnostics. She can be reached at 202-344-4492; mcjackson@venable.com.  

     

    References
    1. See Memorandum of Understanding 225-07-7001: Memorandum of Understanding between the United States Food and Drug Administration and the Association of American Feed Control Officials, available at https://bit.ly/2TA43Yw; see also Ingredients & Additives, Food and Drug Administration, https://bit.ly/2UBpq8m 
     
    2. 225-07-7001 Modification: Memorandum of Understanding between the United States Food and Drug Administration and the Association of American Feed Control Officials, available at https://bit.ly/2Fa2sjp
    Related Searches
    • ftc
    • Dietary Supplements
    • Dosage
    • Herb
    Related Knowledge Center
    • Consumer Trends
    • Healthcare Trends
    • Regulations
    Suggested For You
    Asiamerica Group Inc. Asiamerica Group Inc.
    Emerging Regulatory Pathways for Nutraceuticals Emerging Regulatory Pathways for Nutraceuticals
    AHPA Adopts Guidance Policy on Hemp & Hemp-Derived CBD Products AHPA Adopts Guidance Policy on Hemp & Hemp-Derived CBD Products
    GW Pharmaceuticals Receives ABC Tyler Award for Phytomedicinal Research GW Pharmaceuticals Receives ABC Tyler Award for Phytomedicinal Research
    FDA Commissioner Scott Gottlieb to Resign FDA Commissioner Scott Gottlieb to Resign
    Three Steps to Achieve Transparency in Beverages Three Steps to Achieve Transparency in Beverages
    FDA to Hold Meeting on Regulatory Status of CBD in April FDA to Hold Meeting on Regulatory Status of CBD in April
    Nutraceutical Brands Find Relief in Outsourcing Manufacturing Nutraceutical Brands Find Relief in Outsourcing Manufacturing
    Kemin Receives GRAS Approval for Oil-Soluble Green Tea Extract Kemin Receives GRAS Approval for Oil-Soluble Green Tea Extract
    AHPA Revises Hemp-CBD Status Report AHPA Revises Hemp-CBD Status Report
    2018 Farm Bill Brings Victory for Hemp, Uncertainty for CBD 2018 Farm Bill Brings Victory for Hemp, Uncertainty for CBD
    The Magical Mystery Tour Also Known as Cannabis Sativa The Magical Mystery Tour Also Known as Cannabis Sativa
    Consumer Interest in Plant-Based Nutrition Flourishes Consumer Interest in Plant-Based Nutrition Flourishes
    Lonza Consumer Health & Nutrition Granted U.S. Patent for Carniking in Animal Nutrition Lonza Consumer Health & Nutrition Granted U.S. Patent for Carniking in Animal Nutrition
    Aging Cats & Dogs Drive Market for Functional Pet Foods Aging Cats & Dogs Drive Market for Functional Pet Foods

    Related Content

    • Dietary Supplements | Sports Nutrition | Vitamins
      Asiamerica Group Inc.

      Asiamerica Group Inc.

      ...
      Mark Zhang, President 12.22.20

    • Dietary Supplements | Medical Nutrition | Regulations
      Emerging Regulatory Pathways for Nutraceuticals

      Emerging Regulatory Pathways for Nutraceuticals

      Each product class offers unique options for making claims and communicating benefits to consumers and healthcare professionals.
      By Gregory Stephens, Windrose Partners & Sanford Bigelow, PhD, DABT, Vanguard Global Associates LLC 04.01.19

    • Breaking News | Herbs & Botanicals | Quality & Safety | Regulations | Regulatory News
      AHPA Adopts Guidance Policy on Hemp & Hemp-Derived CBD Products

      AHPA Adopts Guidance Policy on Hemp & Hemp-Derived CBD Products

      Supplements and foods that contain hemp or CBD should be manufactured in compliance with applicable federal regulations.
      03.28.19


    • Breaking News | Healthcare Trends | Herbs & Botanicals | Regulations | Research | Research News | World Markets
      GW Pharmaceuticals Receives ABC Tyler Award for Phytomedicinal Research

      GW Pharmaceuticals Receives ABC Tyler Award for Phytomedicinal Research

      UK-based company has pioneered cannabis-based drug development for serious conditions.
      03.25.19

    • Dietary Supplements | Regulations
      FDA Commissioner Scott Gottlieb to Resign

      FDA Commissioner Scott Gottlieb to Resign

      Will agency move forward on efforts to amend DSHEA and pursue a regulatory path for CBD?
      03.11.19

      Trending
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk In Older Adults | Nutraceuticals World
      • Leaven Essential To Launch Branded Botanical Extracts To Global Markets | Nutraceuticals World
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults
      • Oregon Files Lawsuit Against GNC | Nutraceuticals World
      • Vitamin K2 Status May Impact Blood Pressure And Pulse Wave Velocity | Nutraceuticals World
      Breaking News
      • GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      • Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      • Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      • Choline Alone May Improve Maternal DHA Status During Pregnancy
      • Cranberry Consumption Linked to Memory and Neurological Function Improvements
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      Coatings World

      Latest Breaking News From Coatings World

      What Are You Reading?
      Teknos Receives EcoVadis Gold Medal for Sustainability Performance
      AkzoNobel and Partners Team Up to Hack Carbon Reduction Challenges
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      MPO's Most-Read Stories This Week—May 21
      Iterative Scopes Expands its Senior Leadership Team
      Viz.ai Raises $100 Million in Series D Funding
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Piramal Pharma Solutions New API Plant in Canada Now Online
      MG America Appoints Claudio Radossi as President
      Catalent Invests $175M to Expand Mfg. Capabilities at Winchester, KY
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Authentic Beauty Concept Launches Second-Generation ‘Refill Bar’
      HASK Beauty Enters Exclusive Partnership with Amazon
      Garance Doré Launches Made in France Skincare Line
      Happi

      Latest Breaking News From Happi

      P&G Closes HQ Due To Security Threat, Launches New Hair Care Line
      SPF Setting Spray, Lip Contour and Knotless Braids Are Hot Trends: Spate
      Nutrafol Launches Collagen Infusion
      Ink World

      Latest Breaking News From Ink World

      Weekly Recap: Zeller+Gmelin, Sun Chemical and Kornit Top This Week’s News
      Nazdar Celebrates 100 Years with a New Look
      hubergroup Chemicals Exhibits at Paint India for First Time
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Brook + Whittle's new acquisition, SunDance goes to HP and more
      Specialty announces move to new facility
      Mark Andy hosts dealer's open house in Warsaw
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Weekly Recap: Kimberly-Clark to Expand Diaper, Wipes Production in Brazil; The Honest Company to Sell Diapers, Wipes at Walmart & More
      3M to Expand in Nebraska
      Nicely Offers Nonwoven Slitters, Winders
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      ODT's Most Read Stories This Week—May 21
      FDA Clears Anika Therapeutics' X-Twist Knotless Fixation System
      Paragon 28 Rolls Out TenoTac 2.0 Hammertoe and Soft Tissue Repair
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Weekly Recap: Graphene Flagship, Japan Display and LG Display Top This Week’s Stories
      Evonik Launches New Processing Aids for PV Wafer Cutting
      NREL Creates Highest Efficiency 1-Sun Solar Cell

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login